| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
248,920,000 |
| Market
Cap: |
21.57(B) |
| Last
Volume: |
1,501,752 |
Avg
Vol: |
1,818,210 |
| 52
Week Range: |
$62.82 - $97.14 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 212 |
| Guru Rank Value : 5.8 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile International Flavors & Fragrances is a creator and manufacturer of food, beverage, health and biosciences, scent and pharma solutions and complementary adjacent products. Co.'s business segments are: Nourish, which comprises food ingredients, flavor compounds, and savory solutions and inclusions; Health and Biosciences, which comprises a portfolio of enzymes, food cultures, probiotics and other ingredients for food, home and personal care, and health and wellness applications; Scent, which creates fragrance compounds, fragrance ingredients and cosmetic ingredients and personal care products; and Pharma Solutions, which produces cellulosics and seaweed-based pharma excipients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
1,972 |
12,601 |
| Total Sell Value |
$0 |
$0 |
$170,282 |
$1,503,681 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
1 |
3 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Herriott Simon |
President Health & Biosciences |
• • – |
2022-02-19 |
4 |
D |
$135.03 |
$20,930 |
D/D |
(155) |
4,824 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2022-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
616 |
4,979 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2022-02-19 |
4 |
D |
$135.03 |
$36,863 |
D/D |
(273) |
3,338 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2022-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
708 |
3,611 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2022-02-14 |
4 |
D |
$132.10 |
$15,852 |
D/D |
(120) |
4,418 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
366 |
4,538 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2022-02-14 |
4 |
D |
$132.10 |
$17,437 |
D/D |
(132) |
4,363 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
525 |
4,495 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2022-02-14 |
4 |
D |
$132.10 |
$20,079 |
D/D |
(152) |
2,903 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
366 |
3,055 |
|
- |
|
| Fauchon De Villeplee Christophe |
President, Scent |
• • – |
2022-01-02 |
4 |
OE |
$149.12 |
$116,910 |
D/D |
784 |
7,234 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2021-12-31 |
4 |
D |
$149.82 |
$185,178 |
D/D |
(1,236) |
2,689 |
|
- |
|
| Johnson Jennifer Amy |
EVP, General Counsel |
• • – |
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,241 |
3,925 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-12-31 |
4 |
D |
$149.82 |
$133,490 |
D/D |
(891) |
3,961 |
|
- |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,241 |
4,852 |
|
- |
|
| Strzelecki Angela |
President, Pharma Solutions |
• • – |
2021-12-30 |
4 |
OE |
$115.48 |
$401,986 |
D/D |
3,481 |
4,172 |
|
- |
|
| Freemont Capital Pte Ltd |
10% Owner |
– – • |
2021-09-15 |
4 |
OE |
$143.75 |
$140,731,250 |
I/I |
979,000 |
25,109,000 |
|
- |
|
| Fauchon De Villeplee Christophe |
President, ScentOfficer |
• – – |
2021-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,450 |
|
-3% |
|
| Gordon Ilene S |
Director |
• • – |
2021-05-14 |
4 |
B |
$140.39 |
$140,386 |
D/D |
1,000 |
1,255 |
2.39 |
-6% |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-05-13 |
4 |
S |
$138.47 |
$184,442 |
D/D |
(1,332) |
1,515 |
|
4% |
|
| Herriott Simon |
President Health & Biosciences |
• • – |
2021-05-13 |
4 |
OE |
$115.48 |
$174,721 |
D/D |
1,513 |
2,847 |
|
- |
|
| Schultz Kare |
Director |
• • – |
2021-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
255 |
255 |
|
- |
|
| Gold Christinia A |
Director |
• • – |
2021-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,047 |
6,835 |
|
- |
|
| Heinzel Matthias |
Director |
• • – |
2021-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
255 |
255 |
|
- |
|
| Breen Edward D |
Director |
• • – |
2021-05-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
255 |
455 |
|
- |
|
1472 Records found
|
|
Page 4 of 59 |
|
|
0.17 (0.2%) 
